Please wait while the formulary information is being retrieved.
ABELCET (AMPHOTERICIN B LIPID COMPLEX)
- Aspergillosis
- Blastomycosis
- Candida peritonitis
- Candidal endocarditis
- Candidal meningitis
- Candidal septicemia
- Candidemia
- Candidiasis
- Coccidioidomycosis
- Cryptococcal septicemia
- Cryptococcosis
- Disseminated candidiasis
- Disseminated sporotrichosis
- Fungal endocarditis
- Fungal infection of lung
- Fungal meningitis
- Fungal sepsis
- Fungal urinary tract infection
- Histoplasmosis
- Leishmaniasis
- Mucormycosis
- Pulmonary cryptococcosis
- Rhinocerebral phycomycosis
5 mg/mL intravenous suspension
- Dosage information is not available
Aspergillosis
- Infuse 5 mg/kg by intravenous route once daily
Candida peritonitis
- Infuse 3 mg/kg over 2 hour(s) by intravenous route once daily
- Infuse 3 mg/kg over 2 hour(s) by intravenous route once daily for 14 days
- Infuse 3 mg/kg over 2 hour(s) by intravenous route once daily for 21 days
- Infuse 4 mg/kg over 2 hour(s) by intravenous route once daily for 21 days
- Infuse 4 mg/kg over 2 hour(s) by intravenous route once daily for 14 days
- Infuse 4 mg/kg over 2 hour(s) by intravenous route once daily
Candidal endocarditis
- Infuse 3 mg/kg over 2 hour(s) by intravenous route once daily
- Infuse 3 mg/kg over 2 hour(s) by intravenous route once daily for 14 days
- Infuse 3 mg/kg over 2 hour(s) by intravenous route once daily for 21 days
- Infuse 4 mg/kg over 2 hour(s) by intravenous route once daily for 21 days
- Infuse 4 mg/kg over 2 hour(s) by intravenous route once daily for 14 days
- Infuse 4 mg/kg over 2 hour(s) by intravenous route once daily
Candidal meningitis
- Infuse 3 mg/kg over 2 hour(s) by intravenous route once daily
- Infuse 3 mg/kg over 2 hour(s) by intravenous route once daily for 14 days
- Infuse 3 mg/kg over 2 hour(s) by intravenous route once daily for 21 days
- Infuse 4 mg/kg over 2 hour(s) by intravenous route once daily for 21 days
- Infuse 4 mg/kg over 2 hour(s) by intravenous route once daily for 14 days
- Infuse 4 mg/kg over 2 hour(s) by intravenous route once daily
Candidal septicemia
- Infuse 3 mg/kg over 2 hour(s) by intravenous route once daily
- Infuse 3 mg/kg over 2 hour(s) by intravenous route once daily for 14 days
- Infuse 3 mg/kg over 2 hour(s) by intravenous route once daily for 21 days
- Infuse 4 mg/kg over 2 hour(s) by intravenous route once daily for 21 days
- Infuse 4 mg/kg over 2 hour(s) by intravenous route once daily for 14 days
- Infuse 4 mg/kg over 2 hour(s) by intravenous route once daily
Candidemia
- Infuse 3 mg/kg over 2 hour(s) by intravenous route once daily
- Infuse 3 mg/kg over 2 hour(s) by intravenous route once daily for 14 days
- Infuse 3 mg/kg over 2 hour(s) by intravenous route once daily for 21 days
- Infuse 4 mg/kg over 2 hour(s) by intravenous route once daily for 21 days
- Infuse 4 mg/kg over 2 hour(s) by intravenous route once daily for 14 days
- Infuse 4 mg/kg over 2 hour(s) by intravenous route once daily
Candidiasis
- Infuse 3 mg/kg over 2 hour(s) by intravenous route once daily
- Infuse 3 mg/kg over 2 hour(s) by intravenous route once daily for 14 days
- Infuse 3 mg/kg over 2 hour(s) by intravenous route once daily for 21 days
- Infuse 4 mg/kg over 2 hour(s) by intravenous route once daily for 21 days
- Infuse 4 mg/kg over 2 hour(s) by intravenous route once daily for 14 days
- Infuse 4 mg/kg over 2 hour(s) by intravenous route once daily
Coccidioidomycosis
- Infuse 5 mg/kg by intravenous route once daily
Cryptococcal septicemia
- Infuse 5 mg/kg over 2 hour(s) by intravenous route once daily for 6 weeks
Cryptococcosis
- Infuse 5 mg/kg by intravenous route once daily
Disseminated candidiasis
- Infuse 5 mg/kg by intravenous route once daily
Histoplasmosis
- Infuse 3 mg/kg over 2 hour(s) by intravenous route once daily for 14 days
Leishmaniasis
- Infuse 3 mg/kg over 2 hour(s) by intravenous route once daily
- Infuse 3 mg/kg over 2 hour(s) by intravenous route once daily for 5 days
- Infuse 1 mg/kg over 2 hour(s) by intravenous route once daily for 5 days
- Infuse 1 mg/kg over 2 hour(s) by intravenous route once daily
Mucormycosis
- Infuse 5 mg/kg by intravenous route once daily
Paracoccidioidomycosis
- Infuse 5 mg/kg by intravenous route once daily
Pulmonary cryptococcosis
- Infuse 5 mg/kg over 2 hour(s) by intravenous route once daily for 6 weeks
- cidofovir
- Vistide
Contraindicated
- A-hydrocort
- A-methapred
- Acthar H.p.
- Anucort-hc
- Anusol-hc
- Aristospan Intra-articular
- Aristospan Intralesional
- betamethasone acet & sod phos
- budesonide
- Celestone Soluspan
- clozapine
- Clozaril
- Colocort
- Cortef
- Cortenema
- corticotropin
- Cortifoam
- cortisone
- cyclosporine
- cyclosporine modified
- deferiprone
- Depo-medrol
- dexamethasone
- Dexamethasone Intensol
- dexamethasone sodium phos (PF)
- dexamethasone sodium phosphate
- Dexpak 10 Day
- Dexpak 13 Day
- Dexpak 6 Day
- Digox
- digoxin
- Entocort Ec
- Ez Use Joint-tunnel-trigger
- Fazaclo
- Ferriprox
- First-duke's
- First-mary's Mouthwash
- Flo-pred
- Gengraf
- Grx Hicort 25
- Hemril-30
- hydrocortisone
- hydrocortisone acetate
- hydrocortisone sod succ (PF)
- hydrocortisone sod succinate
- Kenalog
- Lanoxin
- Lanoxin Pediatric
- Medrol
- Medrol (pak)
- methylprednisolone
- methylprednisolone acetate
- methylprednisolone sod suc(PF)
- methylprednisolone sodium succ
- methylprednisolone-bupivacaine
- Millipred
- Millipred Dp
- Neoral
- nystatin-hydrocortisone-diphen
- nystatin-TCN-HC-diphenhydramin
- Orapred
- Orapred Odt
- Pediapred
- Physicians Ez Use M-pred
- prednisolone
- prednisolone acetate
- prednisolone sodium phosphate
- prednisone
- Prednisone Intensol
- Proctocort
- Rayos
- Rectacort-hc
- Sandimmune
- Solu-cortef
- Solu-cortef (pf)
- Solu-medrol
- Solu-medrol (pf)
- triamcinolone acetonide
- triamcinolone hexacetonide
- triamcinolone-lidocaine
- Uceris
- Veripred 20
- Versacloz
Severe
Moderate
- adefovir
- Atripla
- Complera
- efavirenz-emtricitabin-tenofov
- elvitegr-cobicist-emtric-tenof
- emtricitab-rilpivirine-tenofov
- emtricitabine-tenofovir
- gentamicin
- gentamicin in NaCl (iso-osm)
- gentamicin sulfate (ped) (PF)
- gentamicin sulfate (PF)
- Hepsera
- Stribild
- tenofovir disoproxil fumarate
- Truvada
- Viread
- None
Contraindicated
- Hypokalemia
- Hypomagnesemia
- Systemic mastocytosis
Severe
Moderate
- Kidney disease with reduction in GFR
ABELCET (AMPHOTERICIN B LIPID COMPLEX)
- Aspergillosis
- Blastomycosis
- Candida peritonitis
- Candidal endocarditis
- Candidal meningitis
- Candidal septicemia
- Candidemia
- Candidiasis
- Coccidioidomycosis
- Cryptococcal septicemia
- Cryptococcosis
- Disseminated candidiasis
- Disseminated sporotrichosis
- Fungal endocarditis
- Fungal infection of lung
- Fungal meningitis
- Fungal sepsis
- Fungal urinary tract infection
- Histoplasmosis
- Leishmaniasis
- Mucormycosis
- Pulmonary cryptococcosis
- Rhinocerebral phycomycosis
- Chills
- Fever
- Headache disorder
- Nausea and vomiting
- Abdominal pain with cramps
- Anorexia
- Diarrhea
- Gastrointestinal irritation
- Nausea
- Vomiting
More Frequent
Severe
Less Severe
- Anemia
- Kidney disease with reduction in GFR
- Leukopenia
- Severe dyspnea
- Thrombocytopenic disorder
- None
Less Frequent
Severe
Less Severe
Rare / Very Rare
Severe
- None
Less Severe
- None
Contraindicated
None
Severe Precaution
None
Management or Monitoring Precaution
None
Amphotericin B(inject)
- Severity Level:
B
- Additional Notes:
Contraindicated
None
General | Excretion Potential | Effect on Infant | Notes |
None |
Precaution Exists
Amphotericin B (inj)
Insufficient data available
General | Excretion Potential | Effect on Infant | Notes |
Evaluate use carefully | Unknown | Not known; no or inclusive data | Insufficient data available |
No Known Risk
None
General | Excretion Potential | Effect on Infant | Notes |
None |
Contraindicated
None
Precaution Exists
None
No Known Risk
None
- None
Aspergillosis | |
B44 | Aspergillosis |
B44.0 | Invasive pulmonary aspergillosis |
B44.1 | Other pulmonary aspergillosis |
B44.2 | Tonsillar aspergillosis |
B44.7 | Disseminated aspergillosis |
B44.8 | Other forms of aspergillosis |
B44.81 | Allergic bronchopulmonary aspergillosis |
B44.89 | Other forms of aspergillosis |
B44.9 | Aspergillosis, unspecified |
Blastomycosis | |
B40 | Blastomycosis |
B40.0 | Acute pulmonary blastomycosis |
B40.1 | Chronic pulmonary blastomycosis |
B40.2 | Pulmonary blastomycosis, unspecified |
B40.3 | Cutaneous blastomycosis |
B40.7 | Disseminated blastomycosis |
B40.8 | Other forms of blastomycosis |
B40.81 | Blastomycotic meningoencephalitis |
B40.89 | Other forms of blastomycosis |
B40.9 | Blastomycosis, unspecified |
Candida peritonitis | |
B37.89 | Other sites of candidiasis |
K65.0 | Generalized (acute) peritonitis |
T85.71 | Infection and inflammatory reaction due to peritoneal dialysis catheter |
T85.71xA | Infection and inflammatory reaction due to peritoneal dialysis catheter, initial encounter |
Candidal endocarditis | |
B37.6 | Candidal endocarditis |
Candidal meningitis | |
B37.5 | Candidal meningitis |
Candidal septicemia | |
B37.7 | Candidal sepsis |
Candidemia | |
B37.7 | Candidal sepsis |
Candidiasis | |
B37 | Candidiasis |
B37.0 | Candidal stomatitis |
B37.1 | Pulmonary candidiasis |
B37.2 | Candidiasis of skin and nail |
B37.3 | Candidiasis of vulva and vagina |
B37.4 | Candidiasis of other urogenital sites |
B37.41 | Candidal cystitis and urethritis |
B37.42 | Candidal balanitis |
B37.49 | Other urogenital candidiasis |
B37.5 | Candidal meningitis |
B37.6 | Candidal endocarditis |
B37.7 | Candidal sepsis |
B37.8 | Candidiasis of other sites |
B37.81 | Candidal esophagitis |
B37.82 | Candidal enteritis |
B37.83 | Candidal cheilitis |
B37.84 | Candidal otitis externa |
B37.89 | Other sites of candidiasis |
B37.9 | Candidiasis, unspecified |
P37.5 | Neonatal candidiasis |
Coccidioidomycosis | |
B38 | Coccidioidomycosis |
B38.0 | Acute pulmonary coccidioidomycosis |
B38.1 | Chronic pulmonary coccidioidomycosis |
B38.2 | Pulmonary coccidioidomycosis, unspecified |
B38.3 | Cutaneous coccidioidomycosis |
B38.4 | Coccidioidomycosis meningitis |
B38.7 | Disseminated coccidioidomycosis |
B38.8 | Other forms of coccidioidomycosis |
B38.81 | Prostatic coccidioidomycosis |
B38.89 | Other forms of coccidioidomycosis |
B38.9 | Coccidioidomycosis, unspecified |
Cryptococcal septicemia | |
B45.7 | Disseminated cryptococcosis |
Cryptococcosis | |
B45 | Cryptococcosis |
B45.0 | Pulmonary cryptococcosis |
B45.1 | Cerebral cryptococcosis |
B45.2 | Cutaneous cryptococcosis |
B45.3 | Osseous cryptococcosis |
B45.7 | Disseminated cryptococcosis |
B45.8 | Other forms of cryptococcosis |
B45.9 | Cryptococcosis, unspecified |
Disseminated candidiasis | |
B37.5 | Candidal meningitis |
B37.6 | Candidal endocarditis |
B37.7 | Candidal sepsis |
B37.89 | Other sites of candidiasis |
Disseminated sporotrichosis | |
B42.7 | Disseminated sporotrichosis |
Fungal endocarditis | |
B37.6 | Candidal endocarditis |
Fungal infection of lung | |
B37.1 | Pulmonary candidiasis |
J16.8 | Pneumonia due to other specified infectious organisms |
Fungal meningitis | |
B37.5 | Candidal meningitis |
B38.4 | Coccidioidomycosis meningitis |
B39.9 | Histoplasmosis, unspecified |
B45.1 | Cerebral cryptococcosis |
Fungal sepsis | |
B37.7 | Candidal sepsis |
B44.7 | Disseminated aspergillosis |
Fungal urinary tract infection | |
B37.41 | Candidal cystitis and urethritis |
B37.49 | Other urogenital candidiasis |
Histoplasmosis | |
B39 | Histoplasmosis |
B39.0 | Acute pulmonary histoplasmosis capsulati |
B39.1 | Chronic pulmonary histoplasmosis capsulati |
B39.2 | Pulmonary histoplasmosis capsulati, unspecified |
B39.3 | Disseminated histoplasmosis capsulati |
B39.4 | Histoplasmosis capsulati, unspecified |
B39.5 | Histoplasmosis duboisii |
B39.9 | Histoplasmosis, unspecified |
Leishmaniasis | |
B55 | Leishmaniasis |
B55.0 | Visceral leishmaniasis |
B55.1 | Cutaneous leishmaniasis |
B55.2 | Mucocutaneous leishmaniasis |
B55.9 | Leishmaniasis, unspecified |
Mucormycosis | |
B46.0 | Pulmonary mucormycosis |
B46.1 | Rhinocerebral mucormycosis |
B46.2 | Gastrointestinal mucormycosis |
B46.3 | Cutaneous mucormycosis |
B46.4 | Disseminated mucormycosis |
B46.5 | Mucormycosis, unspecified |
Pulmonary cryptococcosis | |
B45.0 | Pulmonary cryptococcosis |
Rhinocerebral phycomycosis | |
B46.1 | Rhinocerebral mucormycosis |
0-9 | A-Z |
---|---|
B37 | Candidiasis |
B37.0 | Candidal stomatitis |
B37.1 | Pulmonary candidiasis |
B37.1 | Pulmonary candidiasis |
B37.2 | Candidiasis of skin and nail |
B37.3 | Candidiasis of vulva and vagina |
B37.4 | Candidiasis of other urogenital sites |
B37.41 | Candidal cystitis and urethritis |
B37.41 | Candidal cystitis and urethritis |
B37.42 | Candidal balanitis |
B37.49 | Other urogenital candidiasis |
B37.49 | Other urogenital candidiasis |
B37.5 | Candidal meningitis |
B37.5 | Candidal meningitis |
B37.5 | Candidal meningitis |
B37.5 | Candidal meningitis |
B37.6 | Candidal endocarditis |
B37.6 | Candidal endocarditis |
B37.6 | Candidal endocarditis |
B37.6 | Candidal endocarditis |
B37.7 | Candidal sepsis |
B37.7 | Candidal sepsis |
B37.7 | Candidal sepsis |
B37.7 | Candidal sepsis |
B37.7 | Candidal sepsis |
B37.8 | Candidiasis of other sites |
B37.81 | Candidal esophagitis |
B37.82 | Candidal enteritis |
B37.83 | Candidal cheilitis |
B37.84 | Candidal otitis externa |
B37.89 | Other sites of candidiasis |
B37.89 | Other sites of candidiasis |
B37.89 | Other sites of candidiasis |
B37.9 | Candidiasis, unspecified |
B38 | Coccidioidomycosis |
B38.0 | Acute pulmonary coccidioidomycosis |
B38.1 | Chronic pulmonary coccidioidomycosis |
B38.2 | Pulmonary coccidioidomycosis, unspecified |
B38.3 | Cutaneous coccidioidomycosis |
B38.4 | Coccidioidomycosis meningitis |
B38.4 | Coccidioidomycosis meningitis |
B38.7 | Disseminated coccidioidomycosis |
B38.8 | Other forms of coccidioidomycosis |
B38.81 | Prostatic coccidioidomycosis |
B38.89 | Other forms of coccidioidomycosis |
B38.9 | Coccidioidomycosis, unspecified |
B39 | Histoplasmosis |
B39.0 | Acute pulmonary histoplasmosis capsulati |
B39.1 | Chronic pulmonary histoplasmosis capsulati |
B39.2 | Pulmonary histoplasmosis capsulati, unspecified |
B39.3 | Disseminated histoplasmosis capsulati |
B39.4 | Histoplasmosis capsulati, unspecified |
B39.5 | Histoplasmosis duboisii |
B39.9 | Histoplasmosis, unspecified |
B39.9 | Histoplasmosis, unspecified |
B40 | Blastomycosis |
B40.0 | Acute pulmonary blastomycosis |
B40.1 | Chronic pulmonary blastomycosis |
B40.2 | Pulmonary blastomycosis, unspecified |
B40.3 | Cutaneous blastomycosis |
B40.7 | Disseminated blastomycosis |
B40.8 | Other forms of blastomycosis |
B40.81 | Blastomycotic meningoencephalitis |
B40.89 | Other forms of blastomycosis |
B40.9 | Blastomycosis, unspecified |
B42.7 | Disseminated sporotrichosis |
B44 | Aspergillosis |
B44.0 | Invasive pulmonary aspergillosis |
B44.1 | Other pulmonary aspergillosis |
B44.2 | Tonsillar aspergillosis |
B44.7 | Disseminated aspergillosis |
B44.7 | Disseminated aspergillosis |
B44.8 | Other forms of aspergillosis |
B44.81 | Allergic bronchopulmonary aspergillosis |
B44.89 | Other forms of aspergillosis |
B44.9 | Aspergillosis, unspecified |
B45 | Cryptococcosis |
B45.0 | Pulmonary cryptococcosis |
B45.0 | Pulmonary cryptococcosis |
B45.1 | Cerebral cryptococcosis |
B45.1 | Cerebral cryptococcosis |
B45.2 | Cutaneous cryptococcosis |
B45.3 | Osseous cryptococcosis |
B45.7 | Disseminated cryptococcosis |
B45.7 | Disseminated cryptococcosis |
B45.8 | Other forms of cryptococcosis |
B45.9 | Cryptococcosis, unspecified |
B46.0 | Pulmonary mucormycosis |
B46.1 | Rhinocerebral mucormycosis |
B46.1 | Rhinocerebral mucormycosis |
B46.2 | Gastrointestinal mucormycosis |
B46.3 | Cutaneous mucormycosis |
B46.4 | Disseminated mucormycosis |
B46.5 | Mucormycosis, unspecified |
B55 | Leishmaniasis |
B55.0 | Visceral leishmaniasis |
B55.1 | Cutaneous leishmaniasis |
B55.2 | Mucocutaneous leishmaniasis |
B55.9 | Leishmaniasis, unspecified |
J16.8 | Pneumonia due to other specified infectious organisms |
K65.0 | Generalized (acute) peritonitis |
P37.5 | Neonatal candidiasis |
T85.71 | Infection and inflammatory reaction due to peritoneal dialysis catheter |
T85.71xA | Infection and inflammatory reaction due to peritoneal dialysis catheter, initial encounter |
Formulary Reference Tool